Pravastatin vs atorvastatin
Pro Research Analysisby 
Searched over 200M research papers
LDL Cholesterol and Lipid-Lowering Efficacy: Atorvastatin vs Pravastatin
Multiple studies show that atorvastatin is more effective than pravastatin at lowering LDL cholesterol and other lipid parameters. Atorvastatin at 10 mg daily reduced LDL cholesterol by 35% compared to 23% for pravastatin 20 mg, and a higher percentage of patients reached target LDL levels with atorvastatin (72% vs 26%) . Similar results were seen in cardiac transplant patients, where atorvastatin led to greater reductions in total cholesterol, LDL cholesterol, and triglycerides than pravastatin, even at lower doses . In another study, atorvastatin reduced LDL cholesterol by 46% compared to 24% for pravastatin . These findings are consistent across different patient populations, including those with diabetes and metabolic syndrome 47.
Cardiovascular Outcomes: Intensive vs Moderate Statin Therapy
In patients with acute coronary syndromes, high-dose atorvastatin (80 mg) reduced both first and recurrent cardiovascular events more than moderate-dose pravastatin (40 mg) over two years. Atorvastatin led to a 16% reduction in first events and a 19% reduction in additional events, resulting in 138 fewer total events compared to pravastatin . This supports the use of more intensive statin therapy for greater cardiovascular protection.
Effects on Oxidative Stress and Antioxidant Properties
Atorvastatin also appears to have stronger antioxidative effects than pravastatin. It reduced markers of oxidative stress, such as malondialdehyde-modified LDL and lipid hydroperoxides, more effectively than pravastatin 24. While both statins reduced some oxidative stress markers, atorvastatin consistently showed greater reductions in lipid oxidation 248.
Inflammatory Markers and Pleiotropic Effects
Atorvastatin reduced inflammatory markers (such as high-sensitivity C-reactive protein and tumor necrosis factor-alpha) and increased adiponectin levels more than pravastatin. However, neither statin significantly affected glucose tolerance in most patients, though atorvastatin increased HbA1c in obese individuals . This suggests atorvastatin may have both advantages and disadvantages regarding metabolic effects.
Lipoprotein(a) Levels
Both atorvastatin and pravastatin increase lipoprotein(a) [Lp(a)] levels, but atorvastatin causes a slightly higher increase. This effect is consistent across multiple studies and may have implications for residual cardiovascular risk .
Bone Health and Statin Therapy
Intensive lipid lowering with atorvastatin was associated with less bone attenuation loss compared to pravastatin in postmenopausal women, suggesting a potential benefit of atorvastatin for bone health in addition to its cardiovascular effects .
Safety and Tolerability
Both atorvastatin and pravastatin have similar safety and tolerability profiles, with no significant differences in adverse events or laboratory abnormalities reported in head-to-head studies 16.
Conclusion
Atorvastatin is generally more effective than pravastatin at lowering LDL cholesterol, improving lipid profiles, and reducing oxidative stress and inflammation. It also provides greater protection against recurrent cardiovascular events and may have additional benefits for bone health. However, atorvastatin may increase Lp(a) levels more than pravastatin and could affect glucose metabolism in some patients. Both drugs are similarly safe and well-tolerated. The choice between them should consider individual patient risk factors and treatment goals.
Sources and full results
Most relevant research papers on this topic
Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia.
Atorvastatin 10 and 20 mg once daily is more effective and safer than pravastatin 20 and 40 mg once daily in treating patients with hypercholesterolemia.
Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients.
Atorvastatin effectively reduces LDL cholesterol and MDA-LDL levels more effectively than pravastatin, with stronger lipid-lowering and antioxidative effects.
Role of statins in the management of dyslipidemia after cardiac transplant: randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin.
Atorvastatin is more effective than pravastatin in reducing total cholesterol, LDL cholesterol, and triglycerides in cardiac transplant patients, with lower doses and comparable tolerability and safety.
DOI